US Patent
US8573209 — Gas delivery device and system
Formulation · Assigned to INO Therapeutics LLC · Expires 2031-01-06 · 5y remaining
Vulnerability score
53/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects a gas delivery system including a device with a valve assembly and a control module that communicates wirelessly with the device.
USPTO Abstract
A gas delivery system including a gas delivery device ( 100 ), a control module ( 200 ) and a gas delivery mechanism is described. An exemplary gas delivery device includes a valve ( 107 ) assembly with a valve and circuit including a memory ( 134 ), a processor ( 122 ) and a transceiver ( 120 ) in communication with the memory. The memory may include gas data such as gas identification, gas expiration and gas concentration. The transceiver on the circuit of the valve assembly may send wireless optical line-of-sight signals to communicate the gas data to a control module. Exemplary gas delivery mechanisms include a ventilator ( 400 ) and a breathing circuit ( 410 ). Methods of administering gas are also described.
Drugs covered by this patent
- Inomax (NITRIC OXIDE) · Vero Biotech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.